ArticleBiomolecules2020
Investigation of α-Glucosidase Inhibitory Metabolites from
Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 38 citations in OpenAlex.
- Differential Inhibitory Mechanisms of Myricetin and Dihydromyricetin on α-Glucosidase: A Combined Molecular Docking, Isothermal Titration Calorimetry and Surface Plasmon Resonance Study.Foods (Basel, Switzerland) · 2026Article
- Evaluation of Anti-Diabetic and Anti-Obesity Potential of Salicornia brachiata Roxb. Seed Oil.Plant foods for human nutrition (Dordrecht, Netherlands) · 2025Article
- Phytoconstituents ofACS omega · 2025Article
- The Anti-Diabetic Effects of Medicinal Plants Belonging to the Liliaceae Family: Potential Alpha Glucosidase Inhibitors.Drug design, development and therapy · 2024Review
- Review
- Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors.Molecules (Basel, Switzerland) · 2023Article
- Metabolomics-Based Profiling via a Chemometric Approach to Investigate the Antidiabetic Property of Different Parts and Origins ofMetabolites · 2023Article
- In Vitro, In Silico and Network Pharmacology Mechanistic Approach to Investigate theMetabolites · 2022Article
- In Vitro and In Vivo Antidiabetic Activity, Phenolic Content and Microscopical Characterization ofMolecules (Basel, Switzerland) · 2022Article
- Evaluation of chemical composition,Heliyon · 2022Article
- Exploring potential antidiabetic and anti-inflammatory flavonoids fromFrontiers in pharmacology · 2022Article
- GC-MS- and NMR-Based Metabolomics and Molecular Docking Reveal the Potential Alpha-Glucosidase Inhibitors fromPharmaceuticals (Basel, Switzerland) · 2021Article
- Bioactive Lipids in Health and Disease.Biomolecules · 2020Article
- Characterization ofMolecules (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stone leaf (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.